| Uniqure N.V.. (10/23/17). "Press Release: Uniqure Announces Proposed Public Offering". Lexington, MA & Amsterdam. |
2017-10-23 |
| UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels. |
2017-10-20 |
| ThromboGenics N.V.. (10/20/17). "Press Release: ThromboGenics Business Update – Q3 2017". Leuven. |
2017-10-20 |
| Uniqure N.V.. (10/19/17). "Press Release: Uniqure Strengthens Intellectual Property Portfolio with Acquisition of Patent Family Providing Broad Protection of the Hyperactive Padua Variant of Factor IX (FIX-Padua)". Lexington, MA & Amsterdam. |
2017-10-19 |
| Uniqure N.V.. (10/19/17). "Press Release: Uniqure Announces Hemophilia B Gene Therapy Program To Enter Pivotal Study With FIX-Padua Variant in 2018". Lexington, MA & Amsterdam. |
2017-10-19 |
| Uniqure N.V.. (10/18/17). "Press Release: Uniqure Presents New Preclinical Data on AMT-130 in Huntington's Disease at the ESGCT 25th Anniversary Congress in Berlin". Lexington, MA & Amsterdam. |
2017-10-18 |
| Ablynx N.V.. (10/17/17). "Press Release: Ablynx Announces Launch of Proposed Global Offering". Ghent. |
2017-10-17 |
| Eurofins Scientific. (10/16/17). "Press Release: Eurofins Expands Its Offering in Food Testing with the Acquisition of Institut Nehring". |
2017-10-16 |
| Ablynx N.V.. (10/16/17). "Press Release: Publication in Accordance with Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Sharholdings (the »Transparency Law«) [Consonance Capital Increases Shareholding in Ablynx to 5.04%]". |
2017-10-16 |
| Eurofins Scientific. (10/12/17). "Press Release: Eurofins to Reinforce Its Forensic Services Portfolio and Footprint with the Acquisition of LGC Forensics". |
2017-10-12 |
| Kiadis Pharma N.V.. (10/10/17). "Press Release: Kiadis Pharma Raises €18.0 Million in a Private Placement of 2.25 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Amsterdam-Duiv |
2017-10-10 |
| Qiagen N.V.. (10/9/17). "Press Release: Qiagen and Centogene to Collaborate in Bioinformatics for Genetic Diseases". Hilden, Rostock & Germantown, MD. |
2017-10-09 |
| ThromboGenics N.V.. (10/9/17). "Press Release: ThromboGenics Announces Publication in Experimental Eye Research of Preclinical Data Supporting Therapeutic Potential of THR-317 in DR". Leuven. |
2017-10-09 |
| BlueBee. (10/9/17). "Press Release: PacBio and BlueBee Launch de Novo Genome Assembly Pipeline on the Bluebee Analysis Platform". Rijskwijk & Menlo Park, CA. |
2017-10-09 |
| Kiadis Pharma N.V.. (10/9/17). "Press Release: Kiadis Pharma Launches a Private Placement of approximately 2.25 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Amsterdam-Duive |
2017-10-09 |
| Uniqure N.V.. (10/6/17). "Press Release: uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntington’s Disease". Lexington, MA & Amsterdam. |
2017-10-06 |
| Celyad S.A.. (10/3/17). "Press Release: Celyad Reports a First Complete Response in a Relapsed Refractory AML Patient in the THINK Trial". Mont-Saint-Guibert. |
2017-10-03 |
| Noxxon Pharma N.V.. (10/3/17). "Press Release: Noxxon Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors". Berlin. |
2017-10-03 |
| Ablynx N.V.. (10/2/17). "Press Release: Ablynx Files Registration Statement for a Proposed Global Offering". Ghent. |
2017-10-02 |
| Ablynx N.V.. (10/2/17). "Press Release: Ablynx Announces Positive Topline Results from the Phase III HERCULES Study of Caplacizumab for the Treatment of Acquired TTP". Ghent. |
2017-10-02 |
| Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin. |
2017-09-29 |
| ThromboGenics N.V.. (9/28/17). "Press Release: ThromboGenics Successfully Introduces New »Already-Diluted« Formulation of Jetrea (ocriplasmin) in the US". Leuven. |
2017-09-28 |
| Noxxon Pharma N.V.. (9/28/17). "Press Release: Noxxon Provides Update on Ongoing Phase 1/2 Clinical Trial with Lead Program NOX-A12". Berlin. |
2017-09-28 |
| Kiadis Pharma N.V.. (9/27/17). "Press Release: Kiadis Pharma Provides Update on the Marketing Authorization Application Process for ATIR101 in Europe". Amsterdam-Duivendrecht. |
2017-09-27 |
| Janssen-Cilag International N.V.. (9/26/17). "Press Release: European Commission Approves Symtuza for the Treatment of HIV-1 In Adults and Adolescents in Europe". Beerse. |
2017-09-26 |
| Bone Therapeutics S.A.. (9/22/17). "Press Release: Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB in Japan". Gosselies. |
2017-09-22 |
| Bone Therapeutics S.A.. (9/20/17). "Press Release: Bone Therapeutics Announces All Patients Meet Primary Endpoint in ALLOB Phase I/IIA Delayed-union Study Interim Analysis". Gosselies. |
2017-09-20 |
| Eurofins Scientific. (9/18/17). "Press Release: Eurofins to Expand Its Presence in North America with the Acquisition of EAG Laboratories". |
2017-09-18 |
| ThromboGenics N.V.. (9/18/17). "Press Release: ThromboGenics Regains Global Rights to Jetrea (ocriplasmin)". Leuven. |
2017-09-18 |
| Ncardia. (9/18/17). "Press Release: Ncardia Established Following Pluriomics Axiogenesis Merger". Gosselies, Cologne, Leiden & Philadelphia, PA. |
2017-09-18 |
| Univercells S.A.. (9/12/17). "Press Release: Univercells Appoints Douglas A. Neugold as Chairman of Its Board of Directors". Brussels. |
2017-09-12 |
| Amylon Therapeutics B.V.. (9/12/17). "Press Release: Amylon Therapeutics Announces Seed Investment Round, Focus on CNS disorders". Leiden. |
2017-09-12 |
| Medicen Paris Region. (9/7/17). "Press Release: BioWin and Medicen Focus on Developing Medical Imaging and Digital Health in Europe". Gosselies & Paris. |
2017-09-07 |
| Kiadis Pharma N.V.. (9/5/17). "Press Release: Kiadis Pharma Appoints Karl Hård as Head of Investor Relations and Communications". Amsterdam-Duivendrecht. |
2017-09-05 |
| Oncurious N.V.. (9/1/17). "Press Release: Oncurious NV Acquires Unique Portfolio of Next-generation Immuno-oncology Assets from VIB". Leuven. |
2017-09-01 |
| Eurofins Scientific. (8/30/17). "Press Release: Eurofins Reports Solid H1 2017 Results with 15.6% Revenue Growth on the Back of an Organic growth of about 6% and over 35 Acquisitions". |
2017-08-30 |
| Gilde Healthcare Partners. (8/29/17). "Press Release: Gilde Healthcare Exits Viroclinics Biosciences". Utrecht. |
2017-08-29 |
| European Invesmtent Bank (EIB). (8/28/17). "Press Release: Investment Plan for Europe – EIB Grants Financing to Apeiron". |
2017-08-28 |
| Gilde Healthcare Partners. (8/28/17). "Press Release: Gilde Healthcare Invests in Mercachem and Syncom to Build the Premier European Drug Discovery Contract Research Organization". Utrecht. |
2017-08-28 |
| Kiadis Pharma N.V.. (8/25/17). "Press Release: Kiadis Pharma Announces Financial Results for the Six Months ended June 30, 2017". Amsterdam-Duivendrecht. |
2017-08-25 |
| European Invesmtent Bank (EIB). (8/25/17). "Press Release: Denmark – EIB Finances Enzyme Research with Novozymes A/S". |
2017-08-25 |
| Kiadis Pharma N.V.. (8/17/17). "Press Release: Kiadis Pharma Obtains up to €15 Million Debt Financing from Kreos Capital". Amsterdam-Duivendrecht. |
2017-08-17 |
| Mimetas B.V.. (8/16/17). "Press Release: Mimetas Develops High-Throughput Gut-on-a-chip Technology in Collaboration with Pharmaceutical Company". Leiden. |
2017-08-16 |
| Royal Philips. (8/15/17). "Press Release: Philips Announces Agreement with Lakeland Health for Advanced Monitoring to Improve Patient Safety". Amsterdam & St. Joseph, MI. |
2017-08-15 |
| Eurofins Scientific. (8/10/17). "Press Release: Eurofins Strengthens Its Footprint in Food and Agroscience Testing in Japan with New Acquisitions". |
2017-08-10 |
| Galapagos N.V.. (8/9/17). "Press Release: GLPG1690 Halts Disease Progression in IPF Patients in FLORA Phase 2a Trial". Mechelen. |
2017-08-09 |
| Royal Philips. (8/9/17). "Press Release: Philips Completes Acquisition of The Spectranetics Corporation". Amsterdam & Colorado Springs, CO. |
2017-08-09 |
| Celyad S.A.. (8/4/17). "Press Release: Celyad Announces New Agreements with Celdara Medical and Dartmouth College". Mont-Saint-Guibert. |
2017-08-04 |
| AstraZeneca plc. (8/2/17). "Press Release: US FDA Accepts Regulatory Submission for Acalabrutinib and Grants Priority Review". |
2017-08-02 |
| Corbion N.V.. (8/2/17). "Press Release: Corbion Signs Agreement to Bid for Substantially All of the Assets of Innovative Microalgae Specialist TerraVia". |
2017-08-02 |
| AstraZeneca plc. (8/1/17). "Press Release: Acalabrutinib Granted Breakthrough Therapy Designation by US FDA for the Treatment of Patients with Mantle Cell Lymphoma". |
2017-08-01 |
| Royal Philips. (8/1/17). "Press Release: Philips Completes Transaction with Profound Medical Corp.". Amsterdam. |
2017-08-01 |
| Uniqure N.V.. (7/31/17). "Press Relase: Uniqure Reacquires Development and Commercialization Rights for its Gene Therapy Candidate in Hemophilia B". Lexington, MA & Amsterdam. |
2017-07-31 |
| Eurofins Scientific. (7/31/17). "Press Release: Eurofins Expands Its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX". |
2017-07-31 |
| Kiadis Pharma N.V.. (9/29/17). "Press Release: Kiadis Pharma Appoints Dr. Andrew Sandler as Chief Medical Officer". Amsterdam-Duivendrecht. |
2017-07-29 |
| iTeos Therapeutics S.A.. (7/28/17). "Press Release: iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region". Gosselies. |
2017-07-28 |
| Eurofins Scientific. (7/27/17). "Press Release: Eurofins Strengthens Its Non-invasive Prenatal Testing Technology Portfolio with the Acquisition of a Majority Stake in LifeCodexx". |
2017-07-27 |
| Complix N.V.. (7/27/17). "Press Release: Complix Announces Expanded Strategic Oncology Collaboration with MSD to Develop Cell-Penetrating Alphabodies". Hasselt. |
2017-07-27 |
| Qiagen N.V.. (7/27/17). "Press Release: Qiagen Reports Results for Second Quarter and First Half of 2017". Venlo. |
2017-07-27 |
| Galapagos N.V.. (7/27/17). "Press Release: Servier Licenses GLPG1972 in Osteoarthritis from Galapagos". Mechelen & Suresnes. |
2017-07-27 |
| Galapagos N.V.. (7/27/17). "Press Release: Solid Financials Support R&D Progress. First Half-year financial Results". Mechelen. |
2017-07-27 |
| Ablynx N.V.. (7/26/17). "Press Release: Ablynx Receives Fast Track Designation from the FDA for Caplacizumab for the Treatment of Acquired TTP". Ghent. |
2017-07-26 |
| Royal Philips. (7/26/17). "Press Release: Philips and Italian Fatebenefratelli Hospital Sign Multiyear Strategic Partnership to Enable Family-centered Care for Mother and Child". Amsterdam & Rome. |
2017-07-26 |
| Eurofins Scientific. (7/26/17). "Press Release: Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of Advinus Therapeutics". |
2017-07-26 |
| Royal Philips. (7/24/17). "Press Release: Philips' Second Quarter Results 2017". |
2017-07-24 |
| Pharming Group N.V.. (7/21/17). "Press Release: Pharming Announces Completion of Its Refinancing with a Single US$100 Million Debt Facility on Improved Commercial Terms". Leiden. |
2017-07-21 |
| Philips. (7/20/17). "Press Release: Chief Business Leader of Philips’ Personal Health Businesses Pieter Nota to Leave Company". Amsterdam. |
2017-07-20 |
| Ablynx N.V.. (7/20/17). "Press Release: Ablynx and Sanofi Enter into a Strategic Collaboration to Develop Nanobody Product Candidates Focused on Immune-mediated Inflammatory Diseases". Ghent. |
2017-07-20 |
| Celyad S.A.. (7/20/17). "Press Release: Celyad Announces Initiation of the SHRINK Trial". Mont-Saint-Guibert. |
2017-07-20 |
| Royal Philips. (7/18/17). "Press Release: Philips to Strengthen Its Ultrasound Business with the Acquisition of Clinical Applications and Imaging Software Company TomTec". Amsterdam. |
2017-07-18 |
| Eurofins Scientific. (7/18/17). "Press Release: Eurofins Issues EUR 650m New Euro Bond". |
2017-07-18 |
| Ablynx N.V.. (7/17/17). "Press Release: Ablynx Proposes Appointment of Mrs Hilde Windels as a New Independent Director". Ghent. |
2017-07-17 |
| Eurofins Scientific. (7/17/17). "Press Release: Eurofins Announces the Potential Launch of a New Senior EUR 500m Bond on the Back of Strong M&A Activity". |
2017-07-17 |
| Biocartis Group N.V.. (7/12/17). "Press Release: Biocartis’ Idylla Instrument and Idylla Console Exempt from US FDA 510(k) Notification Requirements". Mechelen. |
2017-07-12 |
| Noxxon Pharma N.V.. (7/11/17). "Press Release: Noxxon Pharma Announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the EuroNext Growth Market". Berlin. |
2017-07-11 |
| Eurofins Scientific. (7/10/17). "Press Release: Eurofins Has Signed an Exclusive Agreement to Acquire Amatsigroup to further Expand Its Leadership in Biopharmaceutical Services". |
2017-07-10 |
| Biocartis Group N.V.. (7/10/17). "Press Release: Biocartis and A*STAR’s ETPL Initiate Development of Breast Cancer Assay to Guide Therapy Selection". Singapore & Mechelen. |
2017-07-10 |
| Ablynx N.V.. (7/6/17). "Press Release: Publication in Accordcance with Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (the »Transparancy Law«) [Bank of America Corporation]". Ghent. |
2017-07-06 |
| Eurofins Scientific. (7/5/17). "Press Release: Eurofins Expands Its Footprint in Environment Testing with the Acquisition of Ana Laboratories, Inc. in the USA". |
2017-07-05 |
| Noxxon Pharma N.V.. (7/4/17). "Press Release: Noxxon Announces First Patients Treated in Phase I/II Clinical Trial of NOX-A12 Combined with Keytruda in Metastatic Pancreatic and Colorectal Cancer". Berlin. |
2017-07-04 |
| iTeos Therapeutics S.A.. (6/29/17). "Press Release: iTeos Therapeutics Appoints Mohamed Ragab, M.D., as Vice President, Corporate Development". Gosselies. |
2017-06-29 |
| Royal Philips. (6/28/17). "Press Release: Philips to Acquire The Spectranetics Corporation to Accelerate Expansion in Image-guided Therapy Devices to Treat Cardiac and Peripheral Vascular Disease". Amsterdam & Colorado Springs, CO. |
2017-06-28 |
| BioGeneration Ventures B.V.. (6/27/17). "Press Release: BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target". Naarden. |
2017-06-27 |
| VarmX B.V.. (6/27/17). "Press Release: VarmX Raises Seed Capital for Development of Modified Blood Coagulation Factor X". Leiden. |
2017-06-27 |
| Ablynx N.V.. (6/27/17). "Press Release: Ablynx Achieves Second Milestone in Immuno-oncology Collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA". Ghent. |
2017-06-27 |
| Ablynx N.V.. (6/26/17). "Press Release: Ablynx Initiates a Single and Multiple Dose Phase I Study of Caplacizumab in Healthy Japanese Subjects". Ghent. |
2017-06-26 |
| Eurofins Scientific. (6/26/17). "Press Release: Eurofins Strengthens Its Specialty Clinical Diagnostics Footprint with the Acquisition of the Genoma Laboratory Group in Italy". |
2017-06-26 |
| Eurofins. (6/23/17). "Press Release: Eurofins Expands Its Footprint in the Balkan Region with the Acquisition of Environmental Research & Industrial Co-operation in Slovenia". |
2017-06-23 |
| Royal Philips. (6/22/17). "Press Release: Philips to Acquire Electrical Geodesics, Inc. to Establish Integrated Neurological Imaging, Mapping and Therapy Guidance Portfolio". Amsterdam. |
2017-06-22 |
| Bio Base Europe Pilot Plant (BBEPP). (6/21/17). "Press Release: Europe, Flanders, the Province of East-Flanders and the City of Ghent Invest €9.36 million in the Bio Base Europe Pilot Plant". |
2017-06-21 |
| Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. |
2017-06-20 |
| Argen-X N.V. (Argenx). (6/20/17). "Press Release: Argenx Receives Second Preclinical Milestone Payment in Collaboration with Leo Pharma". Breda & Ghent. |
2017-06-20 |
| Galapagos N.V.. (6/20/17). "Press Release: Galapagos’ R&D Update 2017 – Rapidly Advancing Our Product Candidates". Mechelen. |
2017-06-20 |
| Celyad S.A.. (6/19/17). "Press Release: Celyad Reports Promising Early Results at First Dose Level of the Solid Arm of the THINK Trial". Mont-Saint-Guibert. |
2017-06-19 |
| European Invesmtent Bank (EIB). (6/19/17). "Press Release: EIB Supports Late-stage Development and Production of BiondVax’s Universal Flu Vaccine Candidate under Horizon 2020 Initiative". |
2017-06-19 |
| Helsinn Healthcare S.A.. (6/16/17). "Press Release: Helsinn Investment Fund Leads the Financial Round in GreenBone". Lugano. |
2017-06-16 |
| Biocartis Group N.V.. (6/13/17). "Press Release: Biocartis Launches CE-marked IVD Test for Lung Cancer". Mechelen. |
2017-06-13 |
| Biocartis Group N.V.. (6/13/17). "Press Release: Disclosure of a Transparency Notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings)". Mechelen. |
2017-06-13 |
| Ablynx N.V.. (6/13/17). "Press Release: Ablynx Appoints Markus Ewert as Chief Business Officer". Ghent. |
2017-06-13 |
| Eurofins Scientific. (6/13/17). "Press Release: Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of Alphora Research, Inc.". |
2017-06-13 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
